teva pharmaceutical-sp adr
(TEVA:New York Consolidated)
Statutory Independent Director, Chairman of Audit Committee, Vice Chairman of Human Resources & Compensation Committee, Member of Corporate Governance & Nominating Committee, Member of Finance & Invesment Committee and Member of Corporate Responsibility Committee, Teva Pharmaceutical Industries Limited
|Age||Total Calculated Compensation||This person is connected to 12 board members in 1 different organizations across 1 different industries.|
See Board Relationships
Mr. Joseph Nitzani, also known as Yosi, served as a Vice President, Head of Capital Markets, Client Assets and Private Banking Divisions at Mizrahi-Tefachot Bank Ltd., from 2001 to 2007. Mr. Nitzani served as Managing Director of The Government Companies Authority from 1991 to 1995 and of The Tel-Aviv Stock Exchange from 1983 to 1991. He has been an Independent Director of Teva Pharmaceutical Industries Ltd. since September 2008. He has served as a Director of Adanim ...
5 Basel StreetPhone: 972 3 926 7267
Petach Tikva, -- 49131
Fax: 972 3 923 4050
Board Members Memberships*
Statutory Independent Director, Chairman of Audit Committee, Vice Chairman of Human Resources & Compensation Committee, Member of Corporate Governance & Nominating Committee, Member of Finance & Invesment Committee and Member of Corporate Responsibility Committee
Tel Aviv University
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|Robert L. Parkinson Jr.||Chairman, Chief Executive Officer and President|
Baxter International Inc.
|John C. Lechleiter Ph.D.||Chairman, Chief Executive Officer and President|
Eli Lilly and Company
|Pascal Soriot||Chief Executive Officer, Executive Director and Member of Disclosure Committee|
|J. Michael Pearson||Chairman and Chief Executive Officer|
Valeant Pharmaceuticals International, Inc.
|Yoshihiko Hatanaka||Chief Executive Officer, President and Representative Director|
Astellas Pharma, Inc.
|¥170.0M||Compensation as of Fiscal Year 2014.|